Home › Churg-Strauss Syndrome › NCT02967068
VCRC Tissue Repository
VCRC Tissue Biorepository Collection Protocol
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * A participant will be deemed eligible for this study if the participant is/was enrolled in another one of the VCRC observational/longitudinal protocols (5502, 5503, 5504, 5505, 5506, 5507, 5563) and/or one of the VCRC interventional studies (5522, 5523, 5526, 5527, or 5562). Exclusion Criteria: * Inability to give informed consent (or their guardians in the case of children) and to sign the consent form. * Unwilling to allow the use of their tissue for research.
About the study
The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of these tissue specimens and linked clinical data collected through VCRC studies may lead to the identification and development of a series of translational research projects. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.
Sponsor: University of Pennsylvania · Participants: 1,000 · Started: 2016-11
Contact the study team
Official record on ClinicalTrials.gov — NCT02967068
Locations in the U.S.
| Pennsylvania | University of Pennsylvania, Philadelphia |
Conditions
- Churg-Strauss Syndrome
- Giant Cell Arteritis
- Granulomatosis with Polyangiitis
- IgA Vasculitis
- Polyarteritis Nodosa
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.